Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance.

Antiviral therapy - 1 Dec 2003

Gallant Joel E, Gerondelis Peter Z, Wainberg Mark A, Shulman Nancy S, Haubrich Richard H, St Clair Marty, Lanier Ernest R, Hellmann Nicholas S, Richman Douglas D

Abstract excerpt

Although advances in highly active antiretroviral therapy (HAART) have made long-term suppression of HIV an achievable goal of therapy, a substantial proportion of first-line regimens will eventually fail. Successful longterm treatment requires consideration of downstream treatment options at the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to HIV Reverse Transcriptase

Share to Nucleosides

Share to Nucleotides

Share to Reverse Transcriptase Inhibitors

Share to RNA-Directed DNA Polymerase

Source

Identifiers

PMID: 14760883

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14760883-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance.PMID 14760883Read ↗

A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance.Semantic proximity Read ↗

Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study.Semantic proximity Read ↗

Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypes.Semantic proximity Read ↗

Highly drug-resistant HIV-1 clinical isolates are cross-resistant to many antiretroviral compounds in current clinical development.Semantic proximity Read ↗

HIV-1 integrase strand transfer inhibitors: a review of current drugs, recent advances and drug resistanceSemantic proximity Read ↗

Current insights into reverse transcriptase inhibitor-associated resistance.Semantic proximity Read ↗

Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA.Semantic proximity Read ↗

UPDATE ON DRUG RESISTANCE MUTATIONS IN HIV-1Semantic proximity Read ↗

Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase.Semantic proximity Read ↗

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data.Semantic proximity Read ↗

International perspectives on antiretroviral resistance. Nucleoside reverse transcriptase inhibitor resistance.Semantic proximity Read ↗

Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.